|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Other income | |||||
| Total revenues and other income | |||||
| Research and development costs | |||||
| Marketing - Business development expenses | |||||
| General and administrative expenses | |||||
| Other operating income (expenses) | |||||
| Operating profit (loss) | |||||
| Financial income | |||||
| Financial expenses | |||||
| Financial income (loss) | |||||
| Share of net profit (loss) - Equity method | |||||
| Income tax | |||||
| Net loss for the period | |||||
| Basic loss per share | |||||
| Diluted loss per share | |||||
| Weighted average number of shares outstanding used to calculate basic loss per share | |||||
| Weighted average number of shares outstanding used to calculate diluted loss per share |
Loading...
